Editorial: important insights into prescribing practices and training needs of gastroenterologists regarding use of central neuromodulators in IBS

Aliment Pharmacol Ther. 2021 Aug;54(3):339-340. doi: 10.1111/apt.16495.

Authors

Umair Akbani¹, Dipesh H Vasant^{1

2}

Affiliations

¹ Manchester University NHS Foundation Trust, Manchester, UK.
² Division of Diabetes, Endocrinology and Gastroenterology, University of Manchester, Manchester, UK.

PMID: 34236092
DOI: 10.1111/apt.16495

No abstract available

Publication types

Editorial
Comment

MeSH terms

Gastroenterologists*
Gastroenterology*
Humans
Irritable Bowel Syndrome*
Neurotransmitter Agents / therapeutic use
Surveys and Questionnaires

Substances

Neurotransmitter Agents